Home › Funds › Kynam Capital Management, LP › PRQR

Kynam Capital Management, LP position in PRQR

PROQR THRAPEUTICS N V · Health Care

Kynam Capital Management, LP reported holding 1,566,317 shares of PRQR (PROQR THRAPEUTICS N V) in its Q2 2026 13F filing — a position valued at US$2.9M, representing 0.16% of its reported portfolio and ranking #29 among its reported holdings. Kynam Capital Management, LP has disclosed PRQR holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)1.57M sh
Reported value held$2.91M
Portfolio Weight0.16%
First reportedQ4 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Kynam Capital Management, LP's PRQR position evolved

Kynam Capital Management, LP first disclosed a stake in PRQR in Q4 2024 at 1,750,000 shares (US$4.6M). Across 7 filings, Kynam Capital Management, LP increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 1,566,317 shares valued at US$2.9M.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 1.75M $4.64M New
Q1 2025 1.75M $2.33M Hold
Q2 2025 1.65M $3.36M Reduce
Q3 2025 1.65M $3.51M Hold
Q4 2025 1.57M $3.16M Reduce
Q1 2026 1.57M $2.54M Hold
Q2 2026 1.57M $2.91M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PRQR and 13F data

PRQR (PROQR THRAPEUTICS N V) is a Health Care company. 35 other funds we track also report a position in PRQR — the largest reported positions include Privium Fund Management B.V. (US$10.3M), Ikarian Capital, LLC (US$6.4M), HEIGHTS CAPITAL MANAGEMENT, INC (US$5.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PRQR

All PRQR fund holders →

FAQ

How long has Kynam Capital Management, LP held PRQR?

Kynam Capital Management, LP has disclosed PRQR holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is Kynam Capital Management, LP's current position in PRQR?

As of Q2 2026, Kynam Capital Management, LP holds 1.57M shares of PRQR (PROQR THRAPEUTICS N V), valued at $2.91M, representing 0.16% of its reported portfolio and ranking #29.

Has Kynam Capital Management, LP been buying or selling PRQR?

In the latest 13F filing (Q2 2026), Kynam Capital Management, LP held unchanged its position in PRQR.

Which other funds hold PRQR?

Other major institutional holders of PRQR include Privium Fund Management B.V., Ikarian Capital, LLC, HEIGHTS CAPITAL MANAGEMENT, INC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.